Chemical & Engineering News
June 23, 1997
Copyright © 1997 by the American Chemical Society
COMPANY RESULTS: Established firms showed mixed picture in profitability...
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
|---|---|---|---|---|---|---|
| BASF (Germany) | 1996 | $34,801.3 | $1,860.1 | 5.3% | $2,426.0 | $1,523.9 | 103.4 |
| 1995 | 32,935.1 | 1,647.0 | 5.0 | 2,016.0 | 1,391.9 | 106.6 |
| 1994 | 31,043.1 | 1,596.0 | 2.8 | 1,804.7 | 1,277.5 | 106.3 |
| 1993 | 28,748.7 | 572.0 | 2.0 | 2,759.3 | 1,289.3 | 112.0 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Hoechst (Germany) | 1996 | $33,951.3 | $1,849.3 | 5.4% | $2,557.3 | $2,253.3 | 147.9 |
| 1995 | 34,784.7 | 1,496.7 | 4.3 | 2,249.3 | 2,319.3 | 161.6 |
| 1994 | 33,091.3 | 908.7 | 2.7 | 2,095.3 | 2,246.0 | 165.7 |
| 1993 | 30,698.0 | 504.0 | 1.6 | 2,398.0 | 2,026.0 | 172.5 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Bayer (Germany) | ||||||
| 1996 | $32,405.3 | $1,816.7 | 5.6% | $2,518.0 | $2,405.3 | 142.2 |
| 1995 | 29,720.0 | 1,596.0 | 5.4 | 2,112.7 | 2,172.7 | 142.9 |
| 1994 | 28,946.7 | 1,313.3 | 4.5 | 2,350.0 | 2,118.0 | 148.2 |
| 1993 | 27,338.0 | 914.7 | 3.3 | 2,104.0 | 2,104.7 | 151.9 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Rhône-Poulenc (France) | ||||||
| 1996 | $16,761.3 | $535.2 | 3.2% | $1,397.7 | $1,572.9 | 75.3 |
| 1995 | 16,561.1 | 416.8 | 2.5 | 1,191.4 | 1,374.6 | 82.5 |
| 1994 | 16,856.3 | 374.0 | 3.5 | 1,020.3 | 1,308.6 | 79.0 |
| 1993 | 15,735.2 | 360.2 | 2.3 | 1,212.9 | 1,251.0 | 81.7 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| ICI (U.K.) | ||||||
| 1996 | $16,429.8 | $549.7b | 3.3% | $1,602.4 | $298.3 | 64.0 |
| 1995 | 16,037.8 | 835.5 | 5.2 | 982.4 | 288.9 | 64.8 |
| 1994 | 14,351.1 | 421.7c | 2.9 | 601.3 | 376.4 | 67.5 |
| 1993 | 16,604.7 | 396.7d | 2.4 | 726.2 | 571.6 | 87.1 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Akzo Nobel (Netherlands) | ||||||
| 1996 | $13,309.2 | $781.8 | 5.9% | $1,093.2 | $674.4 | 70.7 |
| 1995 | 12,745.7 | 779.4 | 6.1 | 979.9 | 659.6 | 69.8 |
| 1994e | 1,3172.8 | 698.7 | 5.3 | 968.6 | 666.7 | 70.4 |
| 1993 | 9792.3 | 414.0f | 4.2 | 694.0 | 551.0 | 60.7 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Norsk Hydro (Norway) | ||||||
| 1996 | $13,153.9 | $961.9 | 7.3% | $1,876.3 | $118.9 | 35.4 |
| 1995 | 12,361.9 | 1105.9 | 8.9 | 1,355.9 | 109.0 | 32.4 |
| 1994 | 11,064.2 | 625.8 | 5.7 | 1,066.9 | 93.8 | 32.4 |
| 1993 | 9,667.0 | 464.5 | 4.8 | 1,151.2 | 108.5 | 32.5 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Roche Group (Switzerland) | ||||||
| 1996 | $12,917.5 | $3,154.5 | 24.4% | $1,313.9 | $1,979.0 | 49.0 |
| 1995 | 11,671.5 | 2,728.2 | 23.3 | 1,205.5 | 1,852.8 | 50.5 |
| 1994 | 11,932.0 | 2,313.9 | 19.4 | 1,096.3 | 1,886.7 | 61.4 |
| 1993 | 11,581.7 | 2,004.9 | 17.3 | 1,138.3 | 1,750.0 | 56.1 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Degussa (Germany) | ||||||
| 1996g | $9,165.3 | $200.6 | 2.2% | $386.8 | $313.4 | 26.0 |
| 1995g | 9,211.2 | 198.0 | 2.1 | 326.9 | 287.7 | 27.1 |
| 1994g | 9,181.3 | 115.9 | 1.3 | 307.0 | 270.5 | 27.3 |
| 1993g | 9,902.3 | 80.4 | 0.8 | 330.9 | 311.7 | 32.1 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Solvay (Belgium) | ||||||
| 1996 | $9,106.9 | $372.8h | 4.1% | $904.3 | $397.4 | 35.4 |
| 1995 | 8,828.6 | 404.0 | 4.6 | 665.3 | 381.4 | 38.6 |
| 1994 | 8,469.3 | 224.1i | 2.6 | 642.7 | 371.1 | 39.9 |
| 1993 | 7,885.3 | -128.0j | -- | 620.1 | 389.3 | 43.2 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Air Liquide (France) | ||||||
| 1996 | $6,725.3 | $541.5 | 8.1% | $1,340.0 | $156.6 | 27.8 |
| 1995 | 6,293.1 | 520.0 | 8.3 | 853.3 | 155.4 | 26.1 |
| 1994 | 6,207.6 | 479.4 | 7.7 | 572.8 | 91.7 | 24.6 |
| 1993 | 5,938.4 | 434.9 | 7.3 | 660.0 | 91.0 | 24.8 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| EniChem (Italy) | ||||||
| 1996 | $6,628.6 | $146.4 | 2.2% | $197.7 | $80.4 | 16.8 |
| 1995 | 9,035.6 | 688.9 | 7.9 | 166.6 | 103.0 | 21.3 |
| 1994 | 7,453.0 | -555.4k | -- | 153.6 | 129.0 | 23.5 |
| 1993 | 6,904.7 | -1,729.1l | -- | 329.0 | 140.0 | 30.6 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| BOC International | ||||||
| 1996g | $6,277.5 | $434.6 | 6.9% | $986.3 | $153.8 | 40.9 |
| 1995g | 5,859.6 | 388.9 | 6.6 | 800.2 | 142.9 | 40.1 |
| 1994g | 5,439.8 | 203.3m | 3.7 | 649.1 | 137.4 | 39.4 |
| 1993g | 5,053.1 | 318.4 | 6.3 | 641.7 | 133.2 | 40.3 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| DSM (Netherlands) | ||||||
| 1996 | $6,087.5 | $410.5 | 6.7% | $971.0 | $231.3 | 18.4 |
| 1995 | 5,826.0 | 635.3 | 10.9 | 468.6 | 204.6 | 17.0 |
| 1994 | 5,324.8 | 315.6 | 5.9 | 266.9 | 207.6 | 19.4 |
| 1993 | 4,769.0 | -35.6 | -- | 440.7 | 231.3 | 20.6 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Courtaulds (U.K.) | ||||||
| 1996n | $3,279.1 | $131.2 | 4.0% | $313.3 | $64.0 | 17.0 |
| 1995n | 3,586.1 | 127.6 | 3.6 | 254.6 | 62.5 | 17.0 |
| 1994n | 3,327.8 | 159.9 | 4.8 | 284.2 | 70.3 | 18.5 |
| 1993n | 3,116.2 | 162.0o | 5.2 | 206.9 | 61.2 | 19.0 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Kemira (Finland) | ||||||
| 1996 | $2,932.6 | $134.3 | 4.6% | $261.9 | $61.0 | 10.6 |
| 1995 | 2,689.5 | 120.2 | 4.5 | 201.6 | 52.5 | 10.5 |
| 1994 | 2,546.4 | 49.7 | 2.0 | 143.0 | 50.1 | 11.2 |
| 1993 | 2,577.0 | 60.3 | 2.3 | 185.0 | na | 11.4 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Novo Nordisk (Denmark) | ||||||
| 1996 | $2,564.8 | $310.2 | 12.1% | $308.8 | $387.0 | 13.4 |
| 1995 | 2,366.4 | 269.5 | 11.4 | 209.0 | 336.3 | 13.0 |
| 1994 | 2,332.1 | 246.9 | 10.6 | 299.7 | 327.0 | 12.8 |
| 1993 | 2,097.4 | 245.9 | 11.7 | 412.5 | 300.9 | 11.6 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Laporte (U.K.) | ||||||
| 1996 | $1,660.8 | $141.7p | 8.5% | $103.7 | $17.2 | 5.5 |
| 1995 | 1,667.7 | 124.6q | 7.5 | 112.8 | 17.6 | 7.6 |
| 1994 | 1,506.3 | 137.9 | 9.2 | 92.5 | 16.2 | 7.1 |
| 1993 | 1,396.7 | 121.2 | 8.8 | 76.2 | 15.3 | 7.1 |
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
| Dyno (Norway) | ||||||
| 1996 | $1,506.1 | $37.1 | 2.5% | $165.7 | $19.7 | 7.7 |
| 1995 | 1,550.9 | 38.8r | 2.5 | 107.4 | 18.3 | 7.3 |
| 1994 | 1,554.6 | 64.8 | 4.2 | 100.2 | na | 7.6 |
| 1993 | 1,275.2 | 23.4 | 1.8 | 132.7 | 16.8 | 7.3 |
...as newly formed companies began to make their presence felt
| $ Millions | Net sales | Net income | Profit margina | Capital spending | R&D spending | Employees (thousands) |
|---|---|---|---|---|---|---|
| Novartis (Switzerland) | ||||||
| 1996s | $29,314.7 | $1,864.1t | 6.6% | $1,518.6 | $2,957.9 | 116.2 |
| 1995u | 29,080.1 | 3,411.0v | 11.7 | 1,497.6 | 2,853.6 | 134.0 |
| Borealis | ||||||
| 1996 | $2,742.9 | $108.3 | 3.9% | $232.5 | $61.7 | 6.4 |
| 1995 | 3,090.4 | 353.3 | 11.4 | 130.0 | 65.5 | 6.6 |
| 1994w | 2,747.2 | 71.2 | 2.6 | 71.6 | na | 6.5 |
| SKW Trostberg (Germany) | ||||||
| 1996 | $2,597.0 | $99.7 | 3.8% | $1,048.6 | $103.9 | 14.1 |
| 1995x | 2,575.1 | 79.7 | 3.1 | 564.2 | 103.0 | 10.8 |
| Clariant (Switzerland) | ||||||
| 1996 | $1,890.8 | $110.8 | 5.9% | $79.3 | $51.0 | 8.6 |
| 1995y | 1,735.4 | 85.8 | 4.9 | 72.0 | 55.0 | 8.4 |
| Albright & Wilson (U.K.) | ||||||
| 1996 | $1,339.4 | $68.1 | 5.1% | $62.2 | $13.3 | 4.0 |
| 1995z | 1,318.4 | 60.1 | 4.6 | 65.8 | 12.7 | 4.3 |
a Net income as a percentage of sales. b Excludes nonrecurring charge of $120 million. c Excludes nonrecurring charge of $128 million. d Excludes nonrecurring charges of $181 million. e Acquired Nobel Industries on Nov. 8, 1993. f Excludes nonrecurring charge of $85.6 million. g Fiscal year ends Sept. 30. h Excludes nonrecurring gain of $67.4 million. i Excludes nonrecurring gain of $32.9 million. j Excludes nonrecurring charge of $95.3 million. k Excludes nonrecurring charges of $814 million. l Excludes nonrecurring charges of $657 million. m Excludes nonrecurring charge of $25.9 million. n Fiscal year ends March 31. o Excludes nonrecurring charge of $34.8 million. p Excludes nonrecurring charge of $77.9 million. q Excludes nonrecurring charge of $112 million. r Excludes nonrecurring gain of $14.4 million. s Formed by merger of Ciba and Sandoz on Dec. 20, 1996. t Excludes nonrecurring charge of $1.51 billion. u Pro forma results. v Excludes nonrecurring gain of $97 million. w For/b on March 1, 1994. x Launched on stock market on May 24, 1995. y Spun off from Sandoz on July 1, 1995; first-half results are pro forma. z Launched on stock market on March 8, 1995.
